Journal of Nutrition OpenSOurce Diets- www.ResearchDiets.com

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Augenlicht, L. H.
Right arrow Articles by Velcich, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Augenlicht, L. H.
Right arrow Articles by Velcich, A.

© 2002 The American Society for Nutritional Sciences J. Nutr. 132:3804S-3808S, December 2002


Symposium: Diet, Growth Factors and Cancer

Short Chain Fatty Acids and Colon Cancer1,2

Leonard H. Augenlicht3, John M. Mariadason, Andrew Wilson, Diego Arango, WanCai Yang, Barbara G. Heerdt and Anna Velcich

Department of Oncology, Albert Einstein Cancer Center, Montefiore Medical Center, Bronx, NY 10467

3To whom correspondence should be addressed.E-mail: augen{at}aecom.yu.edu.

The development of intestinal cancer involves complex genetic and epigenetic alterations in the intestinal mucosa. The principal signaling pathway responsible for the initiation of tumor formation, the APC-ß-catenin-TCF4 pathway, regulates both cell proliferation and colonic cell differentiation, but many other intrinsic and extrinsic signals also modulate these cell maturation pathways. The challenge is to understand how signaling and cell maturation are also modulated by nutritional agents. Through gene expression profiling, we have gained insight into the mechanisms by which short chain fatty acids regulate these pathways and the differences in response of gene programs, and of the specific regulation of the c-myc gene, to physiological regulators of intestinal cell maturation, such as butyrate, compared with pharmacological regulators such as the nonsteroidal antiinflammatory drug sulindac. Moreover, we used a combination of gene expression profiling of the response of cells in culture to sulindac and the response of the human mucosa in subjects treated with sulindac for 1 month, coupled with a mouse genetic model approach, to identify the cyclin dependent kinase inhibitor p21WAF1/Cip1 as an important suppressor of Apc-initiated intestinal tumor formation and a necessary component for tumor inhibition by sulindac. Finally, the mucous barrier, secreted by intestinal goblet cells, is the interface between the luminal contents and the intestinal mucosa. We generated a mouse genetic model with a targeted inactivation of the Muc2 gene that encodes the major intestinal mucin. These mice have no recognizable goblet cells due to the failure of cells to synthesize and store mucin. This leads to perturbations in intestinal crypt architecture, increased cellular proliferation and rates of cell migration, decreased apoptosis and development of adenomas and adenocarcinomas in the small and large intestine and the rectum.


KEY WORDS: • intestinal cancer • gene expression profiling • mouse genetic models • mucin • cell maturation




This article has been cited by other articles:


Home page
J Med MicrobiolHome page
T. D. Allen, D. R. Moore, X. Wang, V. Casu, R. May, M. R. Lerner, C. Houchen, D. J. Brackett, and M. M. Huycke
Dichotomous metabolism of Enterococcus faecalis induced by haematin starvation modulates colonic gene expression
J. Med. Microbiol., October 1, 2008; 57(10): 1193 - 1204.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. Tong, Z. Yin, Z. Song, A. Dockendorff, C. Huang, J. Mariadason, R. A. Flavell, R. J. Davis, L. H. Augenlicht, and W. Yang
c-Jun NH2-Terminal Kinase 1 Plays a Critical Role in Intestinal Homeostasis and Tumor Suppression
Am. J. Pathol., July 1, 2007; 171(1): 297 - 303.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
K. Parhar, K. A. Baer, K. Parker, and M. J. Ropeleski
Short-chain fatty acid mediated phosphorylation of heat shock protein 25: effects on camptothecin-induced apoptosis
Am J Physiol Gastrointest Liver Physiol, August 1, 2006; 291(2): G178 - G188.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
W. Yang, A. Velcich, I. Lozonschi, J. Liang, C. Nicholas, M. Zhuang, L. Bancroft, and L. H. Augenlicht
Inactivation of p21WAF1/cip1 Enhances Intestinal Tumor Formation in Muc2-/- Mice
Am. J. Pathol., April 1, 2005; 166(4): 1239 - 1246.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
M. M. Huycke and H. R. Gaskins
Commensal Bacteria, Redox Stress, and Colorectal Cancer: Mechanisms and Models
Experimental Biology and Medicine, July 1, 2004; 229(7): 586 - 597.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J.-J. Liu, J. Zhang, S. Ramanan, J. Julian, D. D. Carson, and S. C. Hooi
Heparin/heparan sulfate interacting protein plays a role in apoptosis induced by anticancer drugs
Carcinogenesis, June 1, 2004; 25(6): 873 - 879.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
L. Klampfer, J. Huang, T. Sasazuki, S. Shirasawa, and L. Augenlicht
Inhibition of Interferon {gamma} Signaling by the Short Chain Fatty Acid Butyrate
Mol. Cancer Res., September 1, 2003; 1(11): 855 - 862.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]